title: Lack of favorable effect of immunomodulators on outbred syngeneic rodent islet transplantation.
abstract: We studied the effect of two immunomodulators, lobenzarit disodium and OK-432, on outbred syngeneic islet transplantation. Six hundred fresh islets taken from two male Wistar rats were transplanted intraportally into other male Wistar rats that had been made diabetic with streptozotocin. Lobenzarit was given to 12 recipients and OK-432 to seven recipients intraperitoneally for 1 month, while nine controls received only intraperitoneal saline. Both drug-treated groups could not maintain lower fasting plasma glucose levels or higher fasting body weights at each time as compared with controls. The islet survival time in lobenzarit-treated (23.5 +/- 8.0 days) and OK-432-treated (25.3 +/- 13.4 days) groups was not longer than that (21.6 +/- 9.4 days) of the control group. All the pancreatic insulin contents of the seven surviving controls, ten surviving lobenzarit and five surviving OK-432 recipients were less than 0.8% of the mean insulin content obtained from 12 normal male rats. The hepatic insulin content of both drug-treated groups was not higher than that of the control group. These results suggest that lobenzarit disodium and OK-432 cannot protect outbred syngeneic islet grafts.
authors.affiliation: Second Department of Internal Medicine, Kobe University School of Medicine, Japan.
authors.forename: S J
authors.initials: SJ
authors.lastname: Shin
authors.forename: H
authors.initials: H
authors.lastname: Taniguchi
authors.forename: Y
authors.initials: Y
authors.lastname: Hara
authors.forename: K
authors.initials: K
authors.lastname: Ejiri
authors.forename: Y
authors.initials: Y
authors.lastname: Morimoto
authors.forename: Y
authors.initials: Y
authors.lastname: Yamashiro
authors.forename: Y
authors.initials: Y
authors.lastname: Ishida
authors.forename: N
authors.initials: N
authors.lastname: Kuroda
authors.forename: K
authors.initials: K
authors.lastname: Ishihara
authors.forename: J H
authors.initials: JH
authors.lastname: Tsai
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D001688:Biological Products / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000378:metabolism / Q000601:surgery*; D006085:Graft Survival / Q000187:drug effects*; D007328:Insulin / Q000032:analysis; D016381:Islets of Langerhans Transplantation; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D010844:Picibanil / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D014185:Transplantation, Isogeneic; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
chemical_list: D000276:Adjuvants, Immunologic; D001688:Biological Products; D001786:Blood Glucose; D007328:Insulin; D062367:ortho-Aminobenzoates; D010844:Picibanil; C015735:lobenzarit